Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloablative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00282282
What this trial is testing

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseGVHD
Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)UnknownNCT06348602
What this trial is testing

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Who this might be right for
Ocular Graft-versus-host Disease
Hospital Universitario Dr. Jose E. Gonzalez 60
Testing effectiveness (Phase 2)Study completedNCT00948753
What this trial is testing

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Abramson Cancer Center at Penn Medicine 38
Early research (Phase 1)UnknownNCT00006347
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Testing effectiveness (Phase 2)Ended earlyNCT01468818
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT07015684
What this trial is testing

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Who this might be right for
Sickling Disorder Due to Hemoglobin S
Columbia University 24
Testing effectiveness (Phase 2)Ended earlyNCT00863330
What this trial is testing

Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Wake Forest University Health Sciences 14
Very early researchStudy completedNCT00013533
What this trial is testing

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

Who this might be right for
Hodgkin LymphomaLymphocytic LeukemiaMixed Cell Leukemia+6 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01457885
What this trial is testing

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Who this might be right for
Acute Myeloblastic Leukemia
University of Michigan Rogel Cancer Center 75
Large-scale testing (Phase 3)Study completedNCT00469729
What this trial is testing

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid Leukemia+4 more
Gamida Cell -Teva Joint Venture Ltd. 101
Not applicableStudy completedNCT01687231
What this trial is testing

Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets

Who this might be right for
Hematologic Malignancies
Duke University 47
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00587054
What this trial is testing

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Who this might be right for
Allogeneic Stem Cell TransplantLeukemiaNon-Hodgkins+3 more
Memorial Sloan Kettering Cancer Center 129
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Early research (Phase 1)Ended earlyNCT02057770
What this trial is testing

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 25
Not applicableStudy completedNCT01683123
What this trial is testing

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMyeloproliferative Disorders+1 more
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 143
Testing effectiveness (Phase 2)UnknownNCT01811368
What this trial is testing

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Joseph Tuscano 20
Testing effectiveness (Phase 2)Study completedNCT00185640
What this trial is testing

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Who this might be right for
Blood CancerLeukemia
Stanford University 303
Testing effectiveness (Phase 2)Study completedNCT02722668
What this trial is testing

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia/Lymphoma+22 more
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT00885833
What this trial is testing

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)

Who this might be right for
Wiskott-Aldrich Syndrome
The Korean Society of Pediatric Hematology Oncology 5
Next Page